Aflibercept in colorectal cancer: Indication of minor added benefit
The drug aflibercept (trade name: Zaltrap) has been approved in Germany since February 2013 in combination with a certain chemotherapy for adults with metastatic colorectal cancer in whom chemotherapy with oxaliplatin could ...
Jul 11, 2013